TY - JOUR
T1 - Are high cumulative doses of erythropoietin neuroprotective in preterm infants? A two year follow-up report
AU - Luciano, Rita Paola Maria
AU - Fracchiolla, Annalisa
AU - Ricci, Daniela
AU - Cota, Francesco
AU - D'Andrea, Vito
AU - Gallini, Francesca
AU - Papacci, Patrizia
AU - Mercuri, Eugenio Maria
AU - Romagnoli, Costantino
PY - 2015
Y1 - 2015
N2 - Preterm infants are at risk for neurodevelopmental sequelae even in absence of major cerebral lesions. The hypothesis that Human Recombinant Erythropoietin (rEpo) could improve the neurodevelopmental outcome in risk neonates has raised the highest interest in recent years.
AB - Preterm infants are at risk for neurodevelopmental sequelae even in absence of major cerebral lesions. The hypothesis that Human Recombinant Erythropoietin (rEpo) could improve the neurodevelopmental outcome in risk neonates has raised the highest interest in recent years.
KW - Follow-up preterm
KW - Follow-up preterm
UR - http://hdl.handle.net/10807/71615
U2 - 10.1186/s13052-015-0171-1
DO - 10.1186/s13052-015-0171-1
M3 - Article
SN - 1720-8424
VL - 41
SP - 64
EP - 64
JO - THE ITALIAN JOURNAL OF PEDIATRICS
JF - THE ITALIAN JOURNAL OF PEDIATRICS
ER -